VALIANT LABORATORIES LTD. share price has zoomed 12% and is presently trading at Rs 152.6.
Meanwhile, the BSE HEALTHCARE index is at 38,446.1 (down 0.3%).
Among the top gainers in the BSE HEALTHCARE index today are SUVEN PHARMACEUTICALS (up 4.6%) and GLAND PHARMA (up 3.6%).
AJANTA PHARMA (down 1.7%) and Cadila Healthcare (down 1.5%) are among the top losers today.
Over the last one year, VALIANT LABORATORIES LTD. has moved up from Rs 0.0 to Rs 152.6, registering a gain of Rs 152.6 .
On the other hand, the BSE HEALTHCARE index has moved up from 25,922.2 to 38,446.1, registering a gain of 48.3% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Glenmark Pharma (up 108.3%), Lupin (up 101.8%) and Cadila Healthcare (up 100.1%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 79,909.2 .
The top losers among the BSE Sensex today are Bajaj Finance (down 1.5%) and M&M (down 1.3%). The most traded stocks in the BSE Sensex are Tata Steel and NTPC.
In the meantime, NSE Nifty is at 24,344.7 (up 0.1%). ONGC and Coal India are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 65,344.2 to 79,909.2, registering a gain of 14,565.0 points (up 22.3%).
VALIANT LABORATORIES LTD. net profit fell {profitpercent} YoY to Rs -12 million for the quarter ended March 2024, compared to a profit of Rs {profitnumberprev} million a year ago. Net sales declined {salespercent} to Rs 306 million during the period as against Rs {salesnumberprev} million in {quarterprev}.
For the year ended March 2023, VALIANT LABORATORIES LTD. reported 5.5% increase in net profit to Rs 290 million compared to net profit of Rs 275 million during FY22. Revenue of the company grew 14.5% to Rs 3,339 million during FY23.
Equitymaster requests your view! Post a comment on "VALIANT LABORATORIES LTD. Gains 12%; BSE HEALTHCARE Index Down 0.3%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!